EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 199 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $275,000 | -42.9% | 5,927 | -50.3% | 0.03% | -43.1% |
| Q3 2017 | $482,000 | +19.3% | 11,927 | 0.0% | 0.05% | +18.6% |
| Q2 2017 | $404,000 | +16.8% | 11,927 | 0.0% | 0.04% | +16.2% |
| Q1 2017 | $346,000 | -11.7% | 11,927 | 0.0% | 0.04% | -19.6% |
| Q4 2016 | $392,000 | +4.3% | 11,927 | 0.0% | 0.05% | 0.0% |
| Q3 2016 | $376,000 | +12.2% | 11,927 | 0.0% | 0.05% | +15.0% |
| Q2 2016 | $335,000 | -22.8% | 11,927 | 0.0% | 0.04% | -16.7% |
| Q1 2016 | $434,000 | -9.0% | 11,927 | 0.0% | 0.05% | +2.1% |
| Q4 2015 | $477,000 | +40.3% | 11,927 | 0.0% | 0.05% | +38.2% |
| Q3 2015 | $340,000 | -13.5% | 11,927 | 0.0% | 0.03% | +30.8% |
| Q2 2015 | $393,000 | +14.6% | 11,927 | 0.0% | 0.03% | -7.1% |
| Q1 2015 | $343,000 | -68.1% | 11,927 | -69.7% | 0.03% | -68.5% |
| Q4 2014 | $1,074,000 | +7.4% | 39,427 | -16.0% | 0.09% | 0.0% |
| Q3 2014 | $1,000,000 | – | 46,927 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |